Precigen, Inc. (PGEN) Misses Q2 EPS by 13c, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Precigen, Inc. (PGEN) Misses Q2 EPS by 13c, Revenues Beat

Precigen Reports Second Quarter and First Half 2020 Financial Results

August 10, 2020 4:10 PM EDT

GERMANTOWN, Md., Aug. 10, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve the lives of patients, today announced second quarter and first half financial results for 2020.

... More